What is renal cancer invasion

Kidney cancer is a very common malignant tumor in the urinary system. The treatment of kidney cancer should be determined according to the stage of kidney cancer and physical condition. Kidney cancer invasion may refer to the renal tumor lesions breaking through the capsule and then metastasizing to the abdominal and pelvic cavity. Kidney cancer may cause cancer thrombus spread and metastasis through blood vessels. Unilateral nephrectomy, cancer thrombectomy or lymph node cleaning can also be performed for kidney cancer invasion. After surgery, some biological immunotherapy and targeted drugs are combined to prolong survival treatment as much as possible.

How is advanced kidney cancer treated?

Kidney cancer is a malignant tumor of the urinary system. Once it reaches the advanced stage, the lesion may be relatively large, or there may be some enlarged lymph nodes around the kidney or thrombosis in the renal blood vessels, etc. This indicates that the stage is not too early and the clinical symptoms may be more severe, mainly including hematuria, pain in the kidney area, and imaging findings of kidney masses. For this type of advanced kidney cancer, nephrectomy is also required. After the operation, biological immunotherapy is also required, mainly the application of interferon or interleukin, and some targeted drugs can also be used for oral treatment, such as oral sorafenib and sunitinib to control the progression of the disease.

What should I pay attention to before kidney cancer surgery?

Kidney cancer is a malignant tumor of the urinary system. Generally speaking, a detailed examination is required before surgery to find out whether there are other lesions. If the lesion is limited to the kidney, unilateral kidney can be surgically removed. The main clinical manifestations are pain in the renal area, and imaging examinations reveal masses in the renal area and hematuria. Kidney cancer is a common malignant tumor in the urinary system. Complete the examination before surgery and eliminate contraindications. After further surgery, the postoperative pathological type and installment payment can be determined. Generally speaking, biological immunotherapy is required after kidney cancer surgery, and some targeted drugs can be used. General radiotherapy and chemotherapy are not very sensitive to kidney cancer.